Immune-Image

22/02/2024

During the roundtable discussion, organised by ttopstart, stakeholders involved in the consortium talked about how we can improve or guarantee an optimal patient journey for those undergoing immune imaging. What are the next steps for ttopstart? Nadia of ttopstart will explain more below.

15/02/2024

Our partner ttopstart organised a roundtable discussion during the Annual Meeting in October. Manou of ttopstart explains in the video below what the objective was of the discussion.

08/02/2024

During the Annual Meeting, our partner ttopstart organised a roundtable discussion with experts from the Immune-Image project. In this short series, we talk with Manou and Nadia of ttopstart about their role within the project, the goal of the roundtable discussion and the next steps.

25/01/2024

During the Annual Meeting, Fabian Schmidt of the University of Tubingen gave a presentation about a new total body PET scanner. This scanner can not only benefit oncology but also has advantages in other fields. Fabian explains the other advantages in the video below.

European Cancer Patient Coalition (ECPC)

18/01/2024

During the Annual Meeting, Fabian Schmidt of the University of Tubingen gave a presentation about a new total body PET scanner. We already talked about the advantages of this scanner, but how can the Immune-Image consortium benefit from this new PET scanner?

European Cancer Patient Coalition (ECPC)

11/01/2024

What are the advantages of the new total-body PET scanner that Fabian Schmidt, PostDoc at the University of Tubingen, is researching?

During the Annual Meeting, Fabian Schmidt gave a presentation about a new total-body PET scanner. In this series, we will dive deeper into the scanner's advantages and how it can benefit Immune-Image.

European Cancer Patient Coalition (ECPC)

04/01/2024

During the Annual Meeting, Fabian Schmidt of the University of Tubingen gave a presentation about a new total-body PET scanner. In this series, we will dive deeper into the scanner's advantages and how it can benefit Immune-Image.

European Cancer Patient Coalition (ECPC)

21/12/2023

This Winter Holidays, we celebrate not only the joy of the season but also the collective dedication of the past year. Thank you for your unwavering commitment to deliver ground-breaking work. Every year, we are one step closer to our goal: developing a novel non-invasive imaging strategy for assessing immune cell activation and dynamics in oncology and inflammatory disease.

Happy Holidays and a Prosperous New Year! 🎁🌟

22/11/2023

Positron Emission Tomography (PET), is a powerful imaging technique that allows researchers to study the activity of cells and tissues within the body. Within Immune-Image, PET imaging is used to study the activity of immune cells in the body. Specifically, researchers are using PET tracers that bind to specific molecules on the surface of immune cells, such as CD8 (cytotoxic T cells) or CD163 (immunosuppressive macrophages). Read more about PET imaging and its advantages in the article: https://lnkd.in/eAYBzEsj

European Cancer Patient Coalition (ECPC)

15/11/2023

We talked with project coordinator Bert Windhorst about the fourth annual meeting and the progress the project has made last year. Have a look at the video below!

European Cancer Patient Coalition (ECPC)

09/11/2023

Personalized medicine is an important approach to cancer treatment. It has been shown that tumors can have different genetic mutations and responses to treatment, even within the same type of cancer. Immune-Image is developing advanced imaging techniques to support personalized treatment, which will improve the cancer patient’s survival and quality of life. Read here how we do this: https://lnkd.in/erdtVhvS

European Cancer Patient Coalition (ECPC)

08/11/2023

Looking back on a productive annual meeting in Barcelona last month! We were delighted to see everyone and to hear about the progress the work packages made. And of course, there was also time for some fun during the paella contest 😋

European Cancer Patient Coalition (ECPC)

07/11/2023

Looking back on a productive annual meeting in Barcelona last month! We were delighted to see everyone and hear about the work packages' progress. And, of course, there was also time for some fun during the paella contest 😋

European Cancer Patient Coalition (ECPC)

25/10/2023

Optical imaging is a powerful tool that enables non-invasive, real-time visualization of biological processes at the cellular and molecular levels. This technique can detect small changes in molecular and cellular activity, making it ideal for monitoring immune responses in real time. Immune-Image utilizes a variety of imaging modalities, including PET, MRI, and optical imaging, to gain insights into the complex interactions between the immune system and various diseases. Read here more about how we use the optical imaging technique: https://www.immune-image.eu/news/optical-imaging/?utm_source=linkedin&utm_medium=social&utm_campaign=week30

European Cancer Patient Coalition (ECPC)

18/10/2023

As the developed methods of the Immune-Image project will soon go to clinical trials to test patients' safety and clinical potential, the project would benefit from a patient panel. We hope to further shape our research and methods by involving patients and understanding their perspectives and needs regarding Immune-Image. We would highly appreciate your input to fulfill your expectations for this patient panel in Immune-Image. Fill in the survey here: https://lnkd.in/eu4qYybu

European Cancer Patient Coalition (ECPC)

11/10/2023

Cancer cells often find ways to evade the immune system’s attacks, allowing them to grow and distribute over the body. Checkpoint inhibitors are a class of drugs that can help the immune system by activating immune cells such as T cells to attack cancer cells. In this blog post, you can read about the role of checkpoint inhibitors in the Immune-Image project: https://www.immune-image.eu/news/checkpoint-inhibitors-and-their-role-in-the-immune-image-project/?utm_source=linkedin&utm_medium=social&utm_campaign=week32

European Cancer Patient Coalition (ECPC)

Checkpoint inhibitors and their role in the Immune-Image project The immune system is our body’s natural defense mechanism against diseases, including cancer. It has evolved to recognize and eliminate abnormal cells before they can cause harm. However, cancer cells often find ways to evade the imm...

05/10/2023

Yesterday, we kicked off the 4th annual meeting! This year promises to be especially exciting as we have new developments to share, including data from the clinical trials we started last year. We are happy to see the whole consortium again and look forward to the interesting presentations and fruitful discussions that are still to come!

European Cancer Patient Coalition (ECPC)

13/05/2022

On 17 May, The Ministry of Culture and Science of the State of North Rhine-Westphalia (Germany) is organizing the digital fair “Horizon Europe for NRW”. This regional event focuses on the participation of North-Rhine Westphalian institutions in European projects.

We are delighted to announce that we are invited to be part of this online event! Dr. Andreas Jacobs will give a brief presentation about Immune-Image and after the opening ceremony our booth will be accessible.

Do you want to know the future-oriented world of European projects from NRW? Read more: http://ow.ly/Kqq150J7bGU